Sol-gel technologies reports third quarter 2020 financial results and corporate update

Ness ziona, israel, nov. 12, 2020 (globe newswire) -- sol-gel technologies, ltd. (nasdaq: slgl), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced financial results for the third quarter ended september 30, 2020 and provided clinical and regulatory updates on its programs.
SLGL Ratings Summary
SLGL Quant Ranking